Holen Sie sich die Stockscreener-App
335.69
0.01%
-0.05
Handel nachbörslich:
335.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$335.74
Offen:
$334.31
24-Stunden-Volumen:
908.39K
Relative Volume:
0.66
Marktkapitalisierung:
$65.12B
Einnahmen:
$321.33B
Nettoeinkommen (Verlust:
$1.57B
KGV:
42.22
EPS:
7.9518
Netto-Cashflow:
$3.21B
1W Leistung:
-0.94%
1M Leistung:
-0.47%
6M Leistung:
+11.84%
1J Leistung:
+41.15%
1-Tages-Spanne:
$333.79
$339.47
1-Wochen-Bereich:
$329.10
$349.55
52-Wochen-Spanne:
$233.61
$377.54
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Vergleichen Sie COR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
335.69 | 65.13B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
816.06 | 100.55B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
201.11 | 48.11B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
77.64 | 9.30B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.38 | 730.44M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
What to expect from Cencora's next quarterly earnings report - MSN
What to Expect From Cencora's Next Quarterly Earnings Report - Barchart.com
Why Cencora Inc. stock is rated strong buyPrice Action & Daily Profit Maximizing Trade Tips - ulpravda.ru
Why Cencora Inc. stock attracts high net worth investorsTrade Exit Report & Fast Gain Swing Trade Alerts - ulpravda.ru
Is Cencora Inc. stock a buy for dividend growth2025 Price Targets & AI Driven Price Predictions - ulpravda.ru
Is It Too Late To Consider Cencora (COR) After A 236% Five Year Run? - simplywall.st
Cencora Inc.: Quiet Rally, Big Expectations – Is The Stock Still A Buy After Its Recent Run? - AD HOC NEWS
How geopolitical tensions affect Cencora Inc. stockWeekly Profit Analysis & Smart Investment Allocation Tips - ulpravda.ru
Will Cencora Inc. stock recover faster than marketJuly 2025 Patterns & Fast Exit and Entry Trade Guides - ulpravda.ru
Will Cencora Inc. (ABG) stock outperform energy sector in 2025Recession Risk & Advanced Technical Signal Analysis - ulpravda.ru
Here's Why You Should Retain Cencora Stock in Your Portfolio Now - The Globe and Mail
Why Cencora (COR) is a Top Value Stock for the Long-Term - Yahoo Finance
Why Cencora Inc. stock attracts HNW investorsHigh Frequency Trading Trends & We Spotted the Next Tesla – See Inside - ulpravda.ru
Here's Why Cencora (COR) is a Strong Growth Stock - Yahoo Finance
Cencora bets big on oncology platform in $5 billion OneOncology deal - MSN
Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release - MarketScreener
Deals tracker: UAB Health acquires Alabama medical group - Modern Healthcare News
Who Owns Cencora? Top Shareholders and Recent Insider Activity - TIKR.com
Cencora stock price target lowered to $360 by BofA on valuation concerns - Investing.com India
B of A Securities Lowers Price Target for Cencora (COR), Maintai - GuruFocus
Cencora Inc. Stock Is Quietly Going Off: Is This Boring Pharma Play Your Next Power Move? - AD HOC NEWS
Gateway Investment Advisers LLC Has $37.23 Million Position in Cencora, Inc. $COR - MarketBeat
Cencora Inc.: Quiet Rally, Strong Fundamentals – Is This Healthcare Stock Underappreciated? - AD HOC NEWS
Synergy Asset Management LLC Takes Position in Cencora, Inc. $COR - MarketBeat
8,971 Shares in Cencora, Inc. $COR Purchased by SteelPeak Wealth LLC - MarketBeat
Generali Asset Management SPA SGR Trims Holdings in Cencora, Inc. $COR - MarketBeat
Market Recap: Why Cencora Inc stock attracts high net worth investorsJuly 2025 Snapshot & Safe Swing Trade Setups - moha.gov.vn
Cencora, Inc. $COR Shares Sold by Ethic Inc. - MarketBeat
Ascent Group LLC Has $1.79 Million Stock Position in Cencora, Inc. $COR - MarketBeat
Dow Update: Why ELLO stock is a value investor pickWeekly Gains Report & Low Drawdown Investment Strategies - moha.gov.vn
Accurate Wealth Management LLC Takes Position in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. (NYSE:COR) Q4 2025 Earnings Call Transcript - MSN
Allspring Global Investments Holdings LLC Purchases 288,148 Shares of Cencora, Inc. $COR - MarketBeat
Cencora Stock: Quiet Rally, Firm Fundamentals and a Market Looking for the Next Catalyst - AD HOC NEWS
Segment Wealth Management LLC Invests $4.83 Million in Cencora, Inc. $COR - MarketBeat
27 Pharma Companies Breached Via US Pharmaceutical Giant Cencora - Telehealth.org
Pacer Advisors Inc. Sells 880,384 Shares of Cencora, Inc. $COR - MarketBeat
Cencora, Inc. (NYSE:COR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Cencora to acquire OneOncology from TPG for $6B - MSN
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Valley National Advisers Inc. Decreases Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora Bets Big on Oncology Platform in $5 Billion OneOncology Deal - MyChesCo
Cencora to Acquire TPG’s Equity Stake in OneOncology, Strengthening Specialty Care Platform - Digital Health News
Burney Co. Cuts Stock Position in Cencora, Inc. $COR - MarketBeat
Exchange Traded Concepts LLC Buys 7,924 Shares of Cencora, Inc. $COR - MarketBeat
Jim Cramer says “I like Cencora a lot” but notes “Cardinal Health’s got them all beat” - MSN
These 3 Medical Stocks Have Wall Street's Bullish Vote for 2026 - TradingView — Track All Markets
Q3 Rundown: Cencora (NYSE:COR) Vs Other Health Insurance Providers Stocks - Finviz
Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora - The Globe and Mail
Patton Fund Management Inc. Trims Position in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Coho Partners Ltd. - MarketBeat
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):